Organization

Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris

3 abstracts

Abstract
Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.
Org: Paris Brain Institute (ICM), Service de Neurologie 2 Mazarin, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, AP-HP, Sorbonne Université, Lyon HCL,
Abstract
International, open-label phase 2 study of regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors (ICI).
Org: Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, Los Angeles, CA, Seoul National University Hospital, Seoul, South Korea,
Abstract
ASSOCIATION BETWEEN ANTIBIOTIC USE AND THE ONSET OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA: A NESTED CASE CONTROL STUDY FROM THE FRENCH E3N-EPIC COHORT STUDY
Org: Universite Paris-Saclay, UVSQ, Inserm, CESP, Villejuif, France, Inserm U567, CESP, UVSQ, AP-HP at Saint-Louis Hospital,